W. Tan

Kinetics and Factors Associated With 12-Month Persistence of Neutralizing Antibody Induced by Two Inactivated COVID-19 Vaccines
20222 citationsauthor #23
DNA Vaccines Expressing the Envelope and Membrane Proteins Provide Partial Protection Against SARS-CoV-2 in Mice
202227 citationsauthor #13
Genome and epigenome editing identify CCR9 and SLC6A20 as target genes at the 3p21.31 locus associated with severe COVID-19
202137 citationsauthor #5
Neutralization of SARS-CoV-2 VOC 501Y.V2 by human antisera elicited by both inactivated BBIBP-CorV and recombinant dimeric RBD ZF2001 vaccines
202164 citationsauthor #6
A tandem-repeat dimeric RBD protein-based covid-19 vaccine zf2001 protects mice and nonhuman primates
202181 citationsauthor #24
Serum sample neutralisation of BBIBP-CorV and ZF2001 vaccines to SARS-CoV-2 501Y.V2
202150 citationsauthor #6
A core-shell structured COVID-19 mRNA vaccine with favorable biodistribution pattern and promising immunity
202199 citationsauthor #26
Immunogenicity and safety of a severe acute respiratory syndrome coronavirus 2 inactivated vaccine in healthy adults: randomized, double-blind, and placebo-controlled phase 1 and phase 2 clinical trials
202147 citationsauthor #16
Ferritin nanoparticle-based SARS-CoV-2 RBD vaccine induces a persistent antibody response and long-term memory in mice
202130 citationsauthor #4
Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon response
2021104 citationsauthor #68
Profiles of SARS-CoV-2 RNA and Antibodies in Inpatients with COVID-19 not Related with Clinical Manifestation: A Single Centre Study
20210 citationsauthor #14
Publisher Correction: A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2
20212 citationsauthor #10
Evolutionary analysis and lineage designation of SARS-CoV-2 genomes
202128 citationsauthor #20
Co-Immunization With CHIKV VLP and DNA Vaccines Induces a Promising Humoral Response in Mice
202121 citationsauthor #11
Real-time reverse transcription-polymerase chain reaction assay panel for the detection of severe acute respiratory syndrome coronavirus 2 and its variants
20218 citationsauthor #6
Genomic characterization of SARS-CoV-2 identified in a reemerging COVID-19 outbreak in Beijing's Xinfadi market in 2020
202029 citationsauthor #9
Description of the First Strain of 2019-nCoV, C-Tan-nCoV Wuhan Strain — National Pathogen Resource Center, China, 2020
202030 citationsauthor #11
T-cell responses to MERS coronavirus infection in people with occupational exposure to dromedary camels in Nigeria: an observational cohort study
202064 citationsauthor #12
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
2020695 citationsauthor #31
Evaluation on clinical performance of a multiplex nucleic acid detection kit RespiFinder® 2SMART in detection of 12 viruses in respiratory tract infections
20200 citationsauthor #5
Non-replicating Vaccinia Virus TianTan Strain (NTV) Translation Arrest of Viral Late Protein Synthesis Associated With Anti-viral Host Factor SAMD9
202011 citationsauthor #7
A Novel Coronavirus from Patients with Pneumonia in China, 2019
202024,260 citationsauthor #18
Genetic tracing of HCoV-19 for the re-emerging outbreak of COVID-19 in Beijing, China
202014 citationsauthor #13
Detection of SARS-CoV-2 in Different Types of Clinical Specimens.
20204,889 citationsauthor #7
Orthogonal genome-wide screenings in bat cells identify MTHFD1 as a target of broad antiviral therapy
202022 citationsauthor #15
Effects of sample processing modes on high-throughput sequencing of coronavirus whole genome/ 不同样本测序前处理方案对冠状病毒基因组高通量测序结果的影响
20201 citationsauthor #7
A Novel Coronavirus Genome Identified in a Cluster of Pneumonia Cases — Wuhan, China 2019−2020
2020686 citationsauthor #1
Comparative Transcriptome Analysis Reveals the Intensive Early Stage Responses of Host Cells to SARS-CoV-2 Infection
202069 citationsauthor #11
Three Novel Real-Time RT-PCR Assays for Detection of COVID-19 Virus
202054 citationsauthor #8
Enterovirus D68 Protease 2Apro Targets TRAF3 To Subvert Host Innate Immune Responses
202029 citationsauthor #8
[Advance on the infectivity of Coronavirus 2019 infection at different stages].
20200 citationsauthor #10
Comparative viromes of Culicoides and mosquitoes reveal their consistency and diversity in viral profiles.
202019 citationsauthor #12
Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China
20202,122 citationsauthor #14
The Pathogenicity of 2019 Novel Coronavirus in hACE2 Transgenic Mice
202024 citationsauthor #43
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
20202,360 citationsauthor #14
A Novel Protein Drug, Novaferon, as the Potential Antiviral Drug for COVID-19
202015 citationsauthor #23
A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2
202076 citationsauthor #10
Ferritin nanoparticle-based SARS-CoV-2 RBD vaccine induces a persistent antibody response and long-term memory in mice
202061 citationsauthor #4
Immune suppression in the early stage of COVID-19 disease
2020199 citationsauthor #10
A distinct name is needed for the new coronavirus
2020317 citationsauthor #6
Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2
20201,664 citationsauthor #18
Reply to “Novaferon, treatment in COVID-19 patients”
20200 citationsauthor #23
Morphogenesis and cytopathic effect of SARS-CoV-2 infection in human airway epithelial cells
2020331 citationsauthor #19
100 Days of COVID-19 Prevention and Control in China
202040 citationsauthor #13
Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro
2020285 citationsauthor #8
Construction and virulence evaluation of nonreplicative vaccinia virus modified strain NTV-C7L
20201 citationsauthor #5
Sequencing the Complete Genome of COVID-19 Virus from Clinical Samples Using the Sanger Method
20207 citationsauthor #6
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
202010,718 citationsauthor #35
Summary of the Detection Kits for SARS-CoV-2 Approved by the National Medical Products Administration of China and Their Application for Diagnosis of COVID-19
202025 citationsauthor #4
Reemergent Cases of COVID-19 — Xinfadi Wholesales Market, Beijing Municipality, China, June 11, 2020
202038 citationsauthor #1
A novel luciferase immunosorbent assay performs better than a commercial enzyme-linked immunosorbent assay to detect MERS-CoV specific IgG in humans and animals
201915 citationsauthor #9
Development and Evaluation of a Universal and Supersensitive NS1-Based Luciferase Immunosorbent Assay to Detect Zika Virus-Specific IgG
20198 citationsauthor #8
Progress in serological detection of Zika virus infection
20190 citationsauthor #3
HBV antigen and DNA loss from mouse serum is associated with novel vaccine‐induced HBV surface antigen‐specific cell‐mediated immunity and cytokine production
20195 citationsauthor #9
Viral and Bacterial Etiology of Acute Febrile Respiratory Syndrome among Patients in Qinghai, China
201919 citationsauthor #6
High-Throughput Screening and Identification of Potent Broad-Spectrum Inhibitors of Coronaviruses
2019271 citationsauthor #11
Progress in mRNA vaccines against influenza viruses
20190 citationsauthor #4
Improving Cross-Protection against Influenza Virus Using Recombinant Vaccinia Vaccine Expressing NP and M2 Ectodomain Tandem Repeats
201912 citationsauthor #4
Establishment and evaluation of receptor binding domain (RBD)-based ELISA for Middle East respiratory syndrome coronavirus (MERS-CoV) antibody detection
20190 citationsauthor #7
Development and optimized pairing of mouse monoclonal antibodies for detecting hemagglutinin in novel H7 subtype influenza viruses
20197 citationsauthor #5
A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike
2019458 citationsauthor #9
Comparison of viral and epidemiological profiles of hospitalized children with severe acute respiratory infection in Beijing and Shanghai, China
201945 citationsauthor #6
Molecular Evidence of Human Monkeypox Virus Infection, Sierra Leone
201928 citationsauthor #12
Non-invasive bioluminescence imaging of HCoV-OC43 infection and therapy in the central nervous system of live mice
201944 citationsauthor #8
Rapid establishment of a mouse model of MERS-CoV pseudovirus infection based on DPP4 transduction
20190 citationsauthor #4
Ultrapotent Human Neutralizing Antibody Repertoires Against Middle East Respiratory Syndrome Coronavirus From a Recovered Patient
201875 citationsauthor #12
The immune response of rhesus macaques to novel vaccines comprising hepatitis B virus S, PreS1, and Core antigens.
20187 citationsauthor #9
Significant Spike-Specific IgG and Neutralizing Antibodies in Mice Induced by a Novel Chimeric Virus-Like Particle Vaccine Candidate for Middle East Respiratory Syndrome Coronavirus
201814 citationsauthor #6
Genotypic Diversity and Epidemiology of Human Rhinovirus Among Children With Severe Acute Respiratory Tract Infection in Shanghai, 2013–2015
201837 citationsauthor #6
Detection of six common human paramyxoviruses in patients with acute febrile respiratory symptoms using a novel multiplex real‐time RT‐PCR assay
20187 citationsauthor #5
Preliminary exploration of replication-defective mechanism of highly attenuated NTV strain of vaccinia virus Tiantan
20181 citationsauthor #6
A novel human mAb (MERS-GD27) provides prophylactic and postexposure efficacy in MERS-CoV susceptible mice
201840 citationsauthor #7
Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus
201848 citationsauthor #10
Serotypes of human rhinoviruses isolated from hospitalized children with severe acute respiratory infection in Shanghai during the autumn and winter of 2016-2017
20181 citationsauthor #4
Combined immunization with human papillomavirus type 18 fusion protein and recombinant vaccinia virus in mice
20180 citationsauthor #7
The persistent prevalence and evolution of cross-family recombinant coronavirus GCCDC1 among a bat population: a two-year follow-up
201724 citationsauthor #14
Recombinant vaccinia vector-based vaccine (Tiantan) boosting a novel HBV subunit vaccine induced more robust and lasting immunity in rhesus macaques.
20178 citationsauthor #8
A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein
201768 citationsauthor #12
Characterization of Glycoproteins and Preparation of HCV Pseudoparticles with High Infectivity of Subtype 3b from Chinese Patients.
20170 citationsauthor #9
Protective T Cell Responses Featured by Concordant Recognition of Middle East Respiratory Syndrome Coronavirus–Derived CD8+ T Cell Epitopes and Host MHC
201744 citationsauthor #19
Discovery of a novel canine respiratory coronavirus support genetic recombination among betacoronavirus1
201740 citationsauthor #8
A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2
201712 citationsauthor #8
Dr. Chi-Ming Chu: Respected founder of molecular virology and pioneer of biologicals in China
20172 citationsauthor #4
Generation and characterization of specific monoclonal antibodies against monkeypox virus
20170 citationsauthor #8
Different infectivity patterns of HCV pseudoparticles derived from glycoproteins of different quasispecies in one patient with HCV subtype 1b infection
20170 citationsauthor #10
Preparation and characteristic analysis of six influenza A (H7N9) pseudovirus derived from different districts of China
20170 citationsauthor #6
Development of a plaque assay based on Avicel-crystal violet staining for detection of Middle East respiratory syndrome coronavirus infection and neutralizing antibody
20170 citationsauthor #8
Progress in development of neutralizing monoclonal antibody (McAb) against MERS-CoV
20170 citationsauthor #3
Mouse MHC class I H-2Kd with a MERS-CoV-derived peptide 142-2
20170 citationsauthor #4
Protective efficacy and hepatitis B virus clearance in mice enhanced by cell‐mediated immunity with novel prime‐boost regimens
20174 citationsauthor #8
A47 Origin and possible genetic recombination of the middle east respiratory syndrome coronavirus from the first imported case in china: phylogenetics and coalescence analysis
201732 citationsauthor #14
[Epidemic and molecular characteristic of human adenovirus infection among patients with febrile respiratory syndrome from a hospital in Qinghai Province, 2012-2015].
20170 citationsauthor #9
Two-tube multiplex real-time reverse transcription PCR to detect six human coronaviruses
201623 citationsauthor #5
Genetic characterization of human bocavirus among children with severe acute respiratory infection in China
201618 citationsauthor #7
Phylogenetic evidence for intratypic recombinant events in a novel human adenovirus C that causes severe acute respiratory infection in children
201628 citationsauthor #7
Prevalence and genetic characterization of enterovirus D68 among children with severe acute respiratory infection in China
20161 citationsauthor #1
Characterization of anti-MERS-CoV antibodies against various recombinant structural antigens of MERS-CoV in an imported case in China
201624 citationsauthor #8
Structural basis of anti-PD-L1 monoclonal antibody avelumab for tumor therapy
2016131 citationsauthor #9
Crystal structure of human PD-L1 with monoclonal antibody avelumab
20160 citationsauthor #9
Establishment of an inactivated viral particle-based ELISA for the detection of anti-MERS-CoV antibodies
20160 citationsauthor #9

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT